Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferasirox in Adult Allogeneic HSCT Recipients With Transfusional Iron Overload
NCT01335035Phase 4Completed
- Sponsor
- Novartis
- Start
- Dec 2008
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of deferasirox in iron overload, sponsored by Novartis. Started Dec 2008; status: completed.
02
Drugs
deferasirox
03
Conditions
iron overload
Beyond the preview
Go deeper on NCT01335035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01335035.